Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Causal link seals Baxter dialyser crisis

This article was originally published in Clinica

Executive Summary

Baxter Healthcare has announced that a processing fluid used in the manufacture of some of its Althane A and AF series dialysers are the "probable cause" of the growing number of suspicious deaths of haemodialysis patients around the world. The findings appear to be confirmed by a report on the first clusters of deaths in Spain. The theory has gained further weight from US Federal Drugs Administration views that there is a growing body of evidence that directly implicates Baxter.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel